IPO Costs Accounting: Treatment, EY Guidance & Common Pitfalls

Getting the accounting for your IPO costs wrong isn't just a technical error. It's a red flag to investors and the SEC, potentially delaying your listing and eroding trust. The rules under US GAAP, specifically ASC 340-10-S99-1, seem straightforward on paper: capitalize direct incremental costs and expense the rest. But in the messy reality of an IPO, the line blurs. Having worked with companies through this process, I've seen the same subtle mistakes trip up even experienced CFOs. This guide breaks down the treatment, incorporates perspective from EY's global IPO leadership, and highlights the pitfalls you won't find in the textbook.

What Exactly Are IPO Costs?

Let's be clear from the start. Not every dollar spent during your IPO journey gets the same accounting treatment. The fundamental split is between direct incremental costs and other IPO-related expenses. This distinction is everything.

Direct Incremental Costs (Capitalize These)

These are costs you would not have incurred if the equity transaction (the IPO) had not occurred. They are directly tied to the success of the offering itself. Think of them as the "cost of sales" for issuing your stock.

  • Professional Fees: This is the big one. It includes fees paid to investment bankers (underwriting discounts and commissions), SEC registration fees, and listing fees paid to exchanges like the NASDAQ or NYSE.
  • Legal & Accounting: Specific legal fees for drafting the S-1 registration statement, responding to SEC comments, and accounting fees directly related to the IPO readiness and SEC compliance work. A crucial nuance: only the incremental portion of your audit fee related to the IPO. Your regular annual audit? That's still an expense.

Other IPO-Related Expenses (Expense These as Incurred)

These are costs related to being a public company or general corporate activities amplified by the IPO process. They would have been incurred in some form regardless of the offering.

  • Roadshow Costs: Travel, hotels, venues. Even though they feel integral to the IPO, they are considered marketing/general corporate and are expensed.
  • Internal Salaries: The time your internal legal, finance, and IR teams spend on the IPO. This is a major area of misallocation. Companies often try to capitalize a portion of internal payroll, but GAAP is generally clear: you can't.
  • Management Bonuses: Bonuses tied to the successful completion of the IPO are compensation expenses, not IPO costs.
  • Upgrading Systems/Internal Controls: Costs to implement new ERP modules, investor relations platforms, or SOX 404 compliance programs. These are costs of being public, not of the securities offering.
Pro Tip: When in doubt, ask: "Would we have spent this money if we decided to pull the IPO tomorrow?" If the answer is yes (like paying your CFO's salary), it's almost certainly an expense.

How to Account for IPO Costs: The Step-by-Step Guide

Here’s the mechanical process. Missing a step can lead to a misstatement.

  1. Identify and Segregate: From day one of IPO preparation, work with your advisors to tag every invoice and time entry. Create a dedicated general ledger account (e.g., "Deferred IPO Costs"). This is a project accounting exercise.
  2. Capitalize Direct Costs: As eligible invoices are approved, book them to the deferred IPO cost asset account. Maintain meticulous supporting documentation linking each cost to a specific IPO-related service.
  3. Expense All Other Costs: Route all other costs (roadshow, internal labor allocations, non-incremental software) through the P&L as normal operating expenses.
  4. Amortization? No. This is a key point. You do not amortize deferred IPO costs over time. They sit on the balance sheet until...
  5. The Offering Completes: When the IPO successfully closes, the total balance in the deferred IPO cost account is reclassified. It is charged against the gross proceeds of the offering in equity. It's not an expense on the income statement; it's a direct reduction of the paid-in capital (APIC) you just raised. Journal entry: Debit APIC, Credit Deferred IPO Costs.
  6. If the IPO Fails: If you abandon the offering, you must immediately expense all previously capitalized deferred IPO costs. This hits the income statement as a one-time, non-operating charge. It's painful, which is why proper classification from the start is critical.

EY's Perspective on IPO Cost Accounting

EY, as one of the dominant auditors for global IPOs, has a well-documented stance. Their guidance often emphasizes the practical application and SEC scrutiny. In their publications, like the Financial Reporting Development: IPO, Spin-off and Carve-out Transactions guide, they stress a few areas that auditors will pick apart.

First, the allocation of legal and accounting fees. EY points out that firms often receive a single, blended invoice. The onus is on the company to obtain a reasonable breakdown from their law firm or auditor between IPO-specific work and ongoing general counsel/audit work. Guessing isn't acceptable.

Second, they highlight the scrutiny on internal salary capitalization. The SEC has repeatedly challenged companies on this. EY's position is conservative: unless you have a highly specific, defensible time-tracking system that isolates work only on tasks like drafting S-1 sections (not general preparation of financials), avoid it. The risk of a future restatement outweighs any benefit.

Finally, EY's global teams often warn about local country variations. If you're a non-US company doing a US listing (e.g., an ADR), you must reconcile home-country GAAP with US GAAP treatment for these costs. The differences can be significant.

A Critical Watch-Out: EY and other Big 4 firms are increasingly focused on costs related to SPAC mergers (de-SPAC transactions) and direct listings. The accounting for costs in these alternative paths to going public can differ from a traditional IPO. Treating them the same is a common and serious error.

Common IPO Accounting Mistakes (And How to Avoid Them)

Based on SEC comment letters and my own experience, here are the top three blunders.

Mistake Why It Happens The Fix
Capitalizing internal salaries & bonuses Feels logical to allocate the huge internal effort. The company views it as a direct cost of the project. Expense them. Full stop. Set expectations with leadership early that this cost will hit the P&L. Implement rigorous time tracking for disclosure purposes, but don't capitalize.
Misclassifying "public company readiness" costs The line between IPO-specific work and building a public company infrastructure is fuzzy. Costs for new software, HR policies, or board recruitment get lumped in. Be brutally honest. Is this a cost we'd incur to become public even via a direct listing or SPAC? If yes, it's a post-IPO operating cost. Keep these projects and their budgets separate from the core IPO "deal" budget.
Poor documentation of cost allocations In the IPO frenzy, paying the invoice and moving on is the priority. The rationale for splitting a $2 million legal bill isn't written down. Treat it like a tax audit. For every capitalized cost, have a file with: the invoice, a description of services, a memo from the provider or internal controller justifying the IPO-specific portion, and approval. This is your first line of defense during audit or SEC review.

A Practical Scenario: Tech Startup 'Nexus AI' Goes Public

Let's make this real. Nexus AI, a SaaS company, is going public via a traditional IPO aiming to raise $200M. Here’s how their costs shook out and how they accounted for them.

Costs Capitalized as Deferred IPO Costs ($4.85M):

  • Underwriting fees (7% of gross proceeds): $14M (Note: This is a direct reduction of proceeds, not a balance sheet asset, but is part of the total "cost" against APIC).
  • SEC registration fee: $150,000
  • NASDAQ listing fee: $75,000
  • Legal fees (incremental portion for S-1 drafting and SEC comments): $500,000 (out of a total $1M legal bill)
  • Audit fees (incremental for IPO work): $125,000 (out of a total $400K audit bill)

Costs Expensed as Incurred ($2.1M):

  • Roadshow travel & events: $400,000
  • Internal team IPO project management (estimated salary allocation): $900,000
  • New investor relations software annual license: $80,000
  • SOX 404 implementation consultant: $720,000

The Accounting Outcome: Upon closing, Nexus AI recorded $4.85M in deferred IPO costs. They then made an equity journal entry reducing the APIC from the offering by that exact amount. The $2.1M in other costs flowed through their income statement over the relevant periods. Their S-1 footnote clearly disclosed both the deferred costs and the types of expenses incurred. This clean breakdown sailed through their audit with EY.

FAQs on IPO Costs and Accounting

Can we capitalize the costs of our roadshow if it's fundamentally about selling the stock?
No, and this is a classic trap. While the roadshow is essential for price discovery and demand generation, accounting standards view it as a marketing and promotional activity. Marketing costs are expensed as incurred, regardless of how critical they are to the deal's success. The logic is that you are promoting the company itself, not directly executing the securities transaction.
Our investment bank gave us a discount on their fee if we hire them for future M&A. How does that affect the IPO cost we capitalize?
You need to allocate the total fee. This is a bundled arrangement. You must estimate the fair value of the future M&A advisory commitment and only capitalize the portion of the fee related to the IPO underwriting services. The rest is a prepayment for future services and should be set up as a separate prepaid asset, then expensed as those future services are rendered. Don't dump the entire discounted fee into deferred IPO costs.
We are considering a direct listing instead of an IPO. Does the accounting for costs change?
Significantly. In a direct listing, there is no capital raise from the company (typically). There are no underwriting fees. The primary costs are SEC registration, legal, and exchange listing fees. The key accounting difference is that since there are no gross proceeds against which to offset the deferred costs, all capitalized costs are expensed immediately upon the effectiveness of the registration statement. This makes cost classification even more critical, as a large misclassified cost will have an immediate, full hit to your P&L.
How should we disclose IPO costs in our financial statement footnotes?
Transparency is key. You should have a footnote, typically under "Stockholders' Equity" or a separate "Initial Public Offering" note, that states: 1) The aggregate amount of deferred IPO costs capitalized as of the balance sheet date, 2) The fact that these will be charged against offering proceeds upon completion, 3) The nature of major cost categories that were expensed during the period (e.g., "IPO-related marketing, compensation, and professional fees expensed were $2.1 million"). This shows the SEC and investors you have a handle on the full picture.
↑